University Hospital Marqués de Valdecilla
Welcome,         Profile    Billing    Logout  
 10 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Casas, Ana Mª Perez
NCT03476473: Early Detection of Respiratory Disorders in Psychosis

Enrolling by invitation
N/A
200
Europe
Fundación Marques de Valdecilla, Instituto de Investigación Marqués de Valdecilla, Consorcio Centro de Investigación Biomédica en Red, M.P.
Schizophrenia, Psychosis, Chronic Respiratory Disease
03/18
12/20
Crespo-Facorro, Benedicto
STEP-ENHANCE, NCT06778564: Stratification and Treatment in Early Psychosis Study - ENHANCE

Not yet recruiting
3
250
Europe, RoW
CBD 100 mg/mL Oral Solution, Placebo
University of Oxford, Wellcome Trust, GW Pharmaceuticals Ltd, Myonex, Cambridge Cognition Ltd, Premier Research Group plc, Diagram B.V., Cambridgeshire and Peterborough NHS Foundation Trust, Oxford Health NHS Foundation Trust, West London NHS Trust, University of Augsburg, Charite University, Berlin, Germany, University of Cologne, Ludwig Maximilian university of Munich, The Sheba Fund for Health Services and Research, Shalvata Mental Health Center, Geha Mental Health Center, Amsterdam University Medical Center, Hospital General Universitario Gregorio Marañon, National and Kapodistrian University of Athens, Medical University of Vienna, Hospitales Universitarios Virgen del Rocío, University of Campania Luigi Vanvitelli, Swansea University, Psychiatric University Hospital, Zurich, IDEA Regulatory
Psychosis, First Episode Psychosis, Psychotic Disorders, Psychotic Episode
12/27
12/28
CLOZ-AID, NCT04529226: Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis

Active, not recruiting
2
75
Europe
Clozapine, Nemex, Leponex, haloperidol, pimozide, olanzapine, risperidone, amisulpride
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Psychosis, Intellectual Disability
01/25
12/25
10PAFIP, NCT02200588: Longitudinal Long-term Study (10 Years) of the Sample of First Episode of Non-affective Psychosis: PAFIP

Enrolling by invitation
N/A
277
Europe
Fundación Marques de Valdecilla, Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Investigación Marqués de Valdecilla
Schizophrenia
12/17
12/20
Bourgon, Javier Vázquez
NCT03481465: Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective Psychosis

Enrolling by invitation
N/A
200
Europe
Fundación Marques de Valdecilla, Instituto de Investigación Marqués de Valdecilla, Consorcio Centro de Investigación Biomédica en Red, M.P.
Schizophrenia, Psychosis, Metabolic Syndrome
12/19
12/20
Infante, Jon
LUMA, NCT05348785 / 2021-004849-20: A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80

Recruiting
2
640
Europe, Canada, Japan, US, RoW
BIIB122, DNL151, BIIB122-Matching Placebo
Biogen, Denali Therapeutics Inc.
Parkinson Disease
12/25
12/25
Ceberio, Jon Infante
LIGHTHOUSE, NCT05418673 / 2022-000747-77: A Study to Assess if BIIB122 Tablets Are Safe and Can Slow Worsening of Early-Stage Parkinson's Disease in Participants With Specific LRRK2 Genetic Variants Between the Ages of 30 and 80 Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale

Terminated
3
7
Europe, US
BIIB122, DNL151, BIIB122-Matching Placebo
Biogen, Denali Therapeutics Inc.
Parkinson Disease
07/23
07/23
MoMoPa-EC, NCT04176302: Monitoring of Mobility of Parkinson's Patients for Therapeutic Purposes - Clinical Trial

Completed
N/A
173
Europe
Parkinson Holter, STAT-ON ® sensor, Motor fluctuations diary, Parkinson's diary, Traditional clinical practice, Clinical interview
Consorci Sanitari de l'Alt Penedès i Garraf, Instituto de Salud Carlos III, European Regional Development Fund
Parkinson Disease
12/22
06/23
ROPAD, NCT03866603: Rostock International Parkinson's Disease Study

Active, not recruiting
N/A
25000
Europe, Canada, US, RoW
CENTOGENE GmbH Rostock
Parkinson´s Disease
12/25
12/25
Lakemeier, S
RWESpine, NCT05082090: A Multi-Center Post-Market Data Collection Protocol to Evaluate the Performance of Orthofix Spine Devices

Recruiting
N/A
2000
Europe, US, RoW
Spinal Surgery
Orthofix Inc.
Spinal Disorders/Injuries
12/31
12/31
laez, M
RWESpine, NCT05082090: A Multi-Center Post-Market Data Collection Protocol to Evaluate the Performance of Orthofix Spine Devices

Recruiting
N/A
2000
Europe, US, RoW
Spinal Surgery
Orthofix Inc.
Spinal Disorders/Injuries
12/31
12/31

Download Options